TCR2 THERAPEUTICS INC.
TCR2 THERAPEUTICS INC. (TCRR) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 190 transactions totaling $82.5M, demonstrating a bullish sentiment with $48.9M in net insider flow. The most recent transaction on Jun 1, 2023 involved a transaction of 4,394,800 shares valued at $0.
TCRR Insider Activity Summary
Who Is Buying TCRR Stock?
No significant insider buying has been recorded for TCRR in the recent period.
Who Is Selling TCRR Stock?
No significant insider selling has been recorded for TCRR in the recent period.
Is TCR2 THERAPEUTICS INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TCRR is bullish with an Insider Alignment Score of 80/100 and a net flow of $48.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TCRR Frequently Asked Questions
Understanding TCRR Insider Activity
Insider trading at TCR2 THERAPEUTICS INC. (TCRR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading TCRR stock, having executed 190 transactions in the past 90 days. The most active insider is Ansbert Gadicke (Executive), who has made 18 transactions totaling $20.9M.
Related Tools
Track TCR2 THERAPEUTICS INC. Insider Activity
Get notified when executives and directors at TCRR file new Form 4 transactions